Graves' Disease & Thyroid Foundation

The Graves’ Disease & Thyroid Foundation provides educational and support services for patients with Graves’ disease, thyroid eye disease & related disorders.

[Spyridoula Maraka @endofellow]

Pleased to share the publication of the new ATA guideline for #thyroid disease in #pregnancy. It was a privilege to serve on the committee and work with an exceptional group of colleagues whose expertise and dedication made this important effort possible. @UAMSEndo @VAWomenVets

[Graves' Disease & Thyroid Foundation @GDATF]

This is a really powerful essay from actor Erin Moriarty on her long battle to get a diagnosis - and the lingering mental health impact of autoimmune diseases. https://t.co/aHrGKxpvoB

[American Thyroid Association @AmThyroidAssn]

BREAKING - 2026 #ATA Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum released! 💡 Key highlights & discussion: https://t.co/Sjy8qhnexa #ThyroidEducation @thyroidjournal @clinicalthyroid

[Autoimmune Association @AutoimmuneAssoc]

Clinical trials are carefully reviewed and monitored to protect participants. Safety is a priority at every stage, with strict guidelines in place.
Get the facts about clinical trials in our latest blog: https://t.co/3igQOjgBqh

[American Thyroid Association @AmThyroidAssn]

🌍Join Us in Celebrating #WorldThyroidDay2026 – May 25th! In 2008, May 25 was officially designated as #WorldThyroidDay by the @ETA_Thyroid. Since 2010, it has been endorsed globally by organizations, including: @AmThyroidAssn, @LATS_Society & #AOTA. https://t.co/HB1tUAW4O5

[Viridian Therapeutics, Inc. @ViridianThera]

Thyroid eye disease (#TED) affects every aspect of people’s lives, and the psychosocial toll is immense.

The insights from our ElevaTED patient survey reveal the critical need for comprehensive care and innovative solutions that address the full, multi-faceted impact of TED.

[American Thyroid Association @AmThyroidAssn]

🗓️Last Chance to Register for 5/18 ATA® Alliance for Thyroid Patient Education Forum. Please share with your patients & colleagues - it's a great opportunity for patients to connect! Save Your Spot Now! https://t.co/etwdOvtGCk #ThyroidAwareness #PatientEducation #ThyroidHealth

[Graves' Disease & Thyroid Foundation @GDATF]

This might be of interest to our patient community, given that some patients with autoimmune thyroid disease also have PMOS (previously known as PCOS).

[Endocrine Society @TheEndoSociety]

PCOS has a new name: Polyendocrine Metabolic Ovarian Syndrome (PMOS). With 50+ patient and professional groups, we helped develop a name that better reflects a condition affecting 1 in 8 women worldwide. Learn more: https://t.co/CvUuEdOlFb #PMOS #PCOS

[Viridian Therapeutics, Inc. @ViridianThera]

The challenges of #ThyroidEyeDisease (#TED) extend far beyond the surface.

The ElevaTED survey gathered insights from more than 200 people living with TED and revealed the extensive hidden challenges people face.

At Viridian, we are committed to making a meaningful difference.

[Graves' Disease & Thyroid Foundation @GDATF]

Check out this insightful read from Medscape News Canada on AI and medical misinformation. (Login might be required to view, but registration should be free.) https://t.co/xhSIdhTpJA

[Viridian Therapeutics, Inc. @ViridianThera]

Today we announced positive topline results from our pivotal phase 3 REVEAL-2 clinical trial which evaluated elegrobart in chronic thyroid eye disease (TED).

Learn more: https://t.co/EMQ0XOESlh

[American Thyroid Association @AmThyroidAssn]

🦋 May is International Thyroid Awareness Month. The ATA® offers 50+ #thyroid brochures for all. 📢 Share and refer patients & colleagues to https://t.co/2nEvxmyexM #ThyroidEducation #InternationalThyroidAwarenessMonth #ThyroidHealth @thyroidjournal @clinicalthyroid

[Graves' Disease & Thyroid Foundation @GDATF]

"I was on set every day just really, really, really struggling to get through it all." Erin Moriarty recently spoke to The Hollywood Reporter about filming "The Boys" after a diagnosis of Graves' disease. https://t.co/zaeYLH0Xx9

[Viridian Therapeutics, Inc. @ViridianThera]

We're headed to #AACE2026 this week! Our team will share data from our THRIVE and ElevaTED studies in #ThyroidEyeDisease. Visit us at booth # 093 to learn how we’re working to address unmet needs for patients with TED.

[American Thyroid Association @AmThyroidAssn]

🗓️ Save the Date: ATA® Thyroid Patient Education Forum, May 18, 8-9:15 PM ET. Join us to connect with #thyroid experts and patients! Register free: https://t.co/MgTBkP1I4X #thyroid

[Graves' Disease & Thyroid Foundation @GDATF]

If you are attending #AAES2026, today is the last day for the exhibit hall - stop by Ballroom 1 and say hello!

[Graves' Disease & Thyroid Foundation @GDATF]

Our blog post warning other patient organizations about WebinarTV was featured in this post from @404mediaco: https://t.co/koBWGVhwdN

[Graves' Disease & Thyroid Foundation @GDATF]

2/2 ...regimen of 12 OBI injections, delivered two weeks apart. The trial met its primary endpoint in moderate-to-severe active TED, showing a 77% proptosis response over 24 weeks (versus 20% placebo).

[Graves' Disease & Thyroid Foundation @GDATF]

1/2 Amgen has announced positive topline results from a Phase 3 trial of TEPEZZA (TM) delivered via an on-body injector (OBI). Patients treated w/ TEPEZZA currently receive eight infusions delivered three weeks apart, but the Phase 3 OBI trial tested a... https://t.co/c4Adldfglr

[Graves' Disease & Thyroid Foundation @GDATF]

2/2 Immunovant will continue to focus on IMVT-1402 (imeroprubart)​, an investigational drug for Graves' disease.

[Graves' Disease & Thyroid Foundation @GDATF]

1/2 Immunovant, Inc. has announced topline results from its Phase 3 trial of batoclimab, noting that the investigational drug failed to meet its primary endpoint (≥2mm reduction in eye bulging after 24 weeks).​
https://t.co/IpTADgfWpj